WVE logo

Wave Life Sciences (WVE) Cash From Operations

Annual CFO

-$19.43 M
+$108.35 M+84.79%

December 31, 2023

Summary

Performance

1-Year Change

+84.79%

3-Year Change

+83.25%

5-Year Change

+15.01%

15-Year Change

+76.78%

WVE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.19%
WVE annual cash flow from operations is higher than 47.19% of companies in Healthcare sector

High & Low

All-time High

-$3.55 M

3-Year Low

-$127.78 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
WVE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 6, 2025
WVE next annual earnings announcement is scheduled for Mar 6, 2025

OtherWVEcash flowmetrics:

Annual CFI

-$1.11 M
WVE annual cash flow from investing activities is -$1.11 million

Annual CFF

$132.53 M
WVE annual cash flow from financing activities is $132.53 million

Annual FCF

-$20.55 M
WVE annual free cash flow is -$20.55 million

Annual CAPEX

$1.11 M
WVE annual capital expenditures is $1.11 million

Quarterly CFO

-$46.48 M
-$19.01 M-69.21%

September 30, 2024

Summary

Performance

3-Month Change

-69.21%

1-Year Change

-39.83%

3-Year Change

-39.83%

5-Year Change

-39.83%

WVE Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.33%
WVE quarterly cash flow from operations is higher than 7.33% of companies in Healthcare sector

High & Low

All-time High

$85.52 M
WVE quarterly cash flow from operations is currently -154.35% below its historical high of $85.52 million

3-Year Low

-$46.48 M
WVE quarterly cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
WVE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 6, 2025
WVE next earnings announcement is scheduled for Mar 6, 2025

OtherWVEcash flowmetrics:

Quarterly CFI

-$383.00 K
WVE quarterly cash flow from investing activities is -$383.00 thousand

Quarterly CFF

$203.75 M
WVE quarterly cash flow from financing activities is $203.75 million

Quarterly FCF

-$46.86 M
WVE quarterly free cash flow is -$46.86 million

Quarterly CAPEX

$383.00 K
WVE quarterly capital expenditures is $383.00 thousand

TTM CFO

-$140.62 M
-$12.02 M-9.35%

September 30, 2024

Summary

Performance

3-Month Change

-9.35%

1-Year Change

-623.67%

3-Year Change

-623.67%

5-Year Change

-623.67%

WVE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.3%
WVE TTM cash flow from operations is higher than 9.3% of companies in Healthcare sector

High & Low

All-time High

-$1.62 M

3-Year Low

-$140.62 M
WVE TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
WVE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 6, 2025
WVE next earnings announcement is scheduled for Mar 6, 2025

OtherWVEcash flowmetrics:

TTM CFI

-$1.21 M
WVE TTM cash flow from investing activities is -$1.21 million

TTM CFF

$312.87 M
WVE TTM cash flow from financing activities is $312.87 million

TTM FCF

-$141.82 M
WVE TTM free cash flow is -$141.82 million

TTM CAPEX

$1.21 M
WVE TTM capital expenditures is $1.21 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

WVE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+84.8%-39.8%-623.7%
3 y3 years+83.3%-39.8%-623.7%
5 y5 years+15.0%-39.8%-623.7%

WVE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+84.8%-154.3%at low-5793.4%at low
5 y5-yearat high+89.7%-154.3%+24.1%-5793.4%+25.3%
alltimeall time-447.2%+89.7%-154.3%+24.1%-8585.4%+25.3%

Wave Life Sciences Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$46.48 M(+69.2%)
-$140.62 M(+9.3%)
Jun 2024
-
-$27.47 M(-17.8%)
-$128.60 M(-7.1%)
Mar 2024
-
-$33.43 M(+0.6%)
-$138.38 M(+612.2%)
Dec 2023
-$19.43 M(-84.8%)
-$33.24 M(-3.5%)
-$19.43 M(-1.0%)
Sep 2023
-
-$34.46 M(-7.5%)
-$19.63 M(+81.4%)
Jun 2023
-
-$37.26 M(-143.6%)
-$10.82 M(+353.5%)
Mar 2023
-
$85.52 M(-355.7%)
-$2.39 M(-98.1%)
Dec 2022
-$127.78 M(+43.6%)
-$33.44 M(+30.4%)
-$127.78 M(+26.0%)
Sep 2022
-
-$25.65 M(-11.0%)
-$101.37 M(-2.4%)
Jun 2022
-
-$28.82 M(-27.7%)
-$103.91 M(+23.0%)
Mar 2022
-
-$39.87 M(+466.9%)
-$84.49 M(-5.1%)
Dec 2021
-$88.99 M(-23.3%)
-$7.03 M(-75.0%)
-$88.99 M(-21.5%)
Sep 2021
-
-$28.18 M(+199.8%)
-$113.38 M(+7.6%)
Jun 2021
-
-$9.40 M(-78.8%)
-$105.36 M(-21.4%)
Mar 2021
-
-$44.38 M(+41.3%)
-$134.11 M(+15.6%)
Dec 2020
-$115.98 M(-38.4%)
-$31.41 M(+55.7%)
-$115.98 M(-20.5%)
Sep 2020
-
-$20.17 M(-47.1%)
-$145.81 M(-13.9%)
Jun 2020
-
-$38.15 M(+45.3%)
-$169.32 M(+3.2%)
Mar 2020
-
-$26.25 M(-57.1%)
-$164.10 M(-12.8%)
Dec 2019
-$188.23 M
-$61.24 M(+40.2%)
-$188.23 M(+17.8%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$43.68 M(+32.7%)
-$159.81 M(+10.1%)
Jun 2019
-
-$32.93 M(-34.6%)
-$145.14 M(+255.6%)
Mar 2019
-
-$50.38 M(+53.5%)
-$40.82 M(+78.5%)
Dec 2018
-$22.86 M(-72.7%)
-$32.82 M(+13.1%)
-$22.86 M(+78.7%)
Sep 2018
-
-$29.01 M(-140.6%)
-$12.80 M(+77.8%)
Jun 2018
-
$71.39 M(-320.2%)
-$7.20 M(-92.7%)
Mar 2018
-
-$32.43 M(+42.5%)
-$98.68 M(+17.9%)
Dec 2017
-$83.67 M(+162.1%)
-$22.75 M(-2.8%)
-$83.67 M(+12.7%)
Sep 2017
-
-$23.41 M(+16.5%)
-$74.26 M(+18.5%)
Jun 2017
-
-$20.09 M(+15.3%)
-$62.69 M(+48.5%)
Mar 2017
-
-$17.42 M(+30.5%)
-$42.21 M(+32.2%)
Dec 2016
-$31.93 M(+154.8%)
-$13.35 M(+12.8%)
-$31.93 M(+26.5%)
Sep 2016
-
-$11.83 M(-3133.8%)
-$25.25 M(+55.2%)
Jun 2016
-
$390.00 K(-105.5%)
-$16.26 M(-9.9%)
Mar 2016
-
-$7.14 M(+7.0%)
-$18.04 M(+44.0%)
Dec 2015
-$12.53 M(+183.0%)
-$6.67 M(+134.1%)
-$12.53 M(+113.8%)
Sep 2015
-
-$2.85 M(+104.6%)
-$5.86 M(+94.6%)
Jun 2015
-
-$1.39 M(-14.0%)
-$3.01 M(+86.0%)
Mar 2015
-
-$1.62 M
-$1.62 M
Dec 2014
-$4.43 M(+24.6%)
-
-
Dec 2013
-$3.55 M
-
-

FAQ

  • What is Wave Life Sciences annual cash flow from operations?
  • What is the all time high annual CFO for Wave Life Sciences?
  • What is Wave Life Sciences annual CFO year-on-year change?
  • What is Wave Life Sciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Wave Life Sciences?
  • What is Wave Life Sciences quarterly CFO year-on-year change?
  • What is Wave Life Sciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Wave Life Sciences?
  • What is Wave Life Sciences TTM CFO year-on-year change?

What is Wave Life Sciences annual cash flow from operations?

The current annual CFO of WVE is -$19.43 M

What is the all time high annual CFO for Wave Life Sciences?

Wave Life Sciences all-time high annual cash flow from operations is -$3.55 M

What is Wave Life Sciences annual CFO year-on-year change?

Over the past year, WVE annual cash flow from operations has changed by +$108.35 M (+84.79%)

What is Wave Life Sciences quarterly cash flow from operations?

The current quarterly CFO of WVE is -$46.48 M

What is the all time high quarterly CFO for Wave Life Sciences?

Wave Life Sciences all-time high quarterly cash flow from operations is $85.52 M

What is Wave Life Sciences quarterly CFO year-on-year change?

Over the past year, WVE quarterly cash flow from operations has changed by -$13.24 M (-39.83%)

What is Wave Life Sciences TTM cash flow from operations?

The current TTM CFO of WVE is -$140.62 M

What is the all time high TTM CFO for Wave Life Sciences?

Wave Life Sciences all-time high TTM cash flow from operations is -$1.62 M

What is Wave Life Sciences TTM CFO year-on-year change?

Over the past year, WVE TTM cash flow from operations has changed by -$121.19 M (-623.67%)